Publications by authors named "Daniela Segala"

Claim this Profile
F
Fever of unknown origin (FUO) FADOI-SIMIT Italian registry: can demographics, comorbidities, and clinical variables predict the etiology of classic FUO?-a prospective Italian study.
Roberto Luzzati, Verena Zerbato, Luciano Attard, Giulio Virgili, Alessandro Cilli, Daniela Segala

Intern Emerg Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer Prevention Pathways in People Living with HIV: Assessment of Prevalence and Related Factors Among Individuals Attending HIV Division of Ferrara Hospital.
Daniela Segala, Mario Stancanelli, Rosario Cultrera

J Pers Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, organizational, and pharmacoeconomic perspectives of dalbavancin vs standard of care in the infectious disease network.
Daniela Segala, Marco Barbieri, Mariachiara Di Nuzzo, Melissa Benazzi, Aurora Bonazza

Glob Reg Health Technol Assess· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Visits to Sexually Transmitted Infection Clinics in Italy from January 2016 to November 2021: A Multicenter, Retrospective Study.
Alessandro Borghi, Maria Elena Flacco, Lucrezia Pacetti, Gionathan Orioni, Elisa Marzola, Daniela Segala

J Pers Med· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Procalcitonin Predicts Bacterial Infection, but Not Long-Term Occurrence of Adverse Events in Patients with Acute Coronary Syndrome.
Rita Pavasini, Gioele Fabbri, Federico Marchini, Nicola Bianchi, Maria Angela Deserio, Daniela Segala

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-Infections in Critically Ill Patients with or without COVID-19: A Comparison of Clinical Microbial Culture Findings.
Rosario Cultrera, Agostino Barozzi, Marco Libanore, Elisabetta Marangoni, Roberto Pora, Daniela Segala

Int J Environ Res Public Health· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and molecular characterization of Subramaniula asteroides causing human fungal keratitis: a case report.
Rosario Cultrera, Riccardo Torelli, Caterina Sarnicola, Daniela Segala, Andrea Mengoli

BMC Infect Dis· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4<200 cells/uL (the PRADAR study).
Cristina Mussini, Enrica Roncaglia, Vanni Borghi, Stefano Rusconi, Silvia Nozza, Daniela Segala

PLoS One· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entheseal involvement in asymptomatic human immunodeficiency virus infected patients: preliminary results of a clinical and ultrasonographic study.
Giovanni Ciancio, Laura Sighinolfi, Federica Furini, Daniela Segala, Ilaria Farina

Clin Exp Rheumatol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.
Lucia Taramasso, Antonio Di Biagio, Francesca Bovis, Laura Ambra Nicolini, Andrea Antinori, Daniela Segala

PLoS One· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disease Progression in HIV Late Presenters: the Role of HIV Clinical Indicator Diseases Prior to HIV Diagnosis.
Viola Guardigni, Mario Luca Morieri, Daniela Segala, Laura Sighinolfi

Curr HIV Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program.
Andreoni Massimo, Elisabetta Teti, Andrea Antinori, Laura Milazzoi, Savatore Sollima, Daniela Segala

Clin Infect Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort study.
Elena Raffetti, Laura Albini, Daria Gotti, Daniela Segala, Franco Maggiolo

BMC Public Health· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic role of systemic inflammatory markers on HIV-infected patients with non-Hodgkin lymphoma, a multicenter cohort study.
Elena Raffetti, Francesco Donato, Filippo Castelnuovo, Nicoletta Ladisa, Giuseppe Paraninfo, Daniela Segala

J Transl Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rate and determinants of residual viremia in multidrug-experienced patients successfully treated with raltegravir-based regimens.
Silvia Baroncelli, Maria Franca Pirillo, Clementina Maria Galluzzo, Anna Degli Antoni, Nicoletta Ladisa, Daniela Segala

AIDS Res Hum Retroviruses· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS.
Carlo Contini, Rosario Cultrera, Silva Seraceni, Daniela Segala, Roberto Romani

J Med Microbiol· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis